Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Apr
30
2024
FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests Sheppard, Mullin, Richter & Hampton LLP
Apr
30
2024
DEA Poised to Reschedule Marijuana Bradley Arant Boult Cummings LLP
Apr
30
2024
Carbon Quarterly - Volume 8 K&L Gates
Apr
30
2024
This Week in 340B: April 23 – April 29, 2024 McDermott Will & Emery
Apr
30
2024
Mixed Algae Conversion Research Opportunity Will Award up to $18.8 Million to Address R&D Challenges in Converting Algae to Biofuels and Bioproducts Bergeson & Campbell, P.C.
Apr
30
2024
It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices Has Arrived Epstein Becker & Green, P.C.
Apr
30
2024
FSIS Declares Salmonella an Adulterant in Chicken Products Keller and Heckman LLP
Apr
30
2024
Will California’s Proposed Acrylamide Warning Amendment Under Proposition 65 Pass Legal Muster? ArentFox Schiff LLP
Apr
30
2024
2024 Florida Alcoholic Beverage Legislation Recap Jones Walker LLP
Apr
29
2024
Crack Open a Cold One: The Future and Legal Considerations for Hemp Beverages Norris McLaughlin P.A.
Apr
29
2024
Do Patent Claims to Methods of Treatment Cover In Vivo Transformations? Mintz
Apr
29
2024
100% Pure, Natural False Advertising Litigation Katten
Apr
29
2024
Cancer Drugs: Strategies For Patenting Antibody-Drug Conjugate Inventions Foley & Lardner LLP
Apr
29
2024
Power Play or Fair Play? 21 Attorneys General Call for Prohibition of Intoxicating Hemp as Industry Faces Existential Threat Bradley Arant Boult Cummings LLP
Apr
26
2024
Chili Competition: Momofuku No Longer Enforcing ‘CHILE CRUNCH’ Trademark Norris McLaughlin P.A.
Apr
26
2024
USDA Publishes Final Rule on School Meals Keller and Heckman LLP
Apr
25
2024
Germany Posts Information on Dossier Submitter’s Ongoing Role in Proposed REACH Restriction for PFAS Bergeson & Campbell, P.C.
Apr
25
2024
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B McDermott Will & Emery
Apr
25
2024
Federal Circuit Affirms Obviousness of Rifaximin Polymorph Patents and Denial of Motion to Modify Judgment After Post-Trial Patented Indication Carve Out Mintz
Apr
25
2024
Florida DOR Proposes Update to Agricultural Real Property Appraisal Guidelines Jones Walker LLP
Apr
25
2024
FTC Moves to Strike Most Noncompetes: Considerations for Cannabis Companies Bradley Arant Boult Cummings LLP
Apr
25
2024
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers Foley & Lardner LLP
Apr
25
2024
Utility of Consortia Advocacy — A Conversation with Heather J. Blankinship [Podcast] Bergeson & Campbell, P.C.
Apr
25
2024
Florida's Division of Alcoholic Beverages and Tobacco Posts 2023 Quota Lottery Winners List Jones Walker LLP
Apr
24
2024
New York’s New Alcohol Beverage Control Law Amendments Affect State Liquor License Applicants Greenberg Traurig, LLP
Apr
24
2024
FDA Continues to Take Stance That it Will Not Issue CBD Rules Foley & Lardner LLP
Apr
24
2024
Trending in Telehealth: March 26 – April 1, 2024 McDermott Will & Emery
Apr
24
2024
Court Dismisses Lawsuit Targeting “All Natural” Claim Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins